The National Institute on Drug Abuse (NIDA) is offering this grant to accelerate drug abuse research by funding innovative analysis of existing social, behavioral, administrative, and neuroimaging data. This grant is for the purpose of studying drug use behaviors (alcohol, tobacco, prescription, and other drugs), their etiology, epidemiology, related disorders, and health service utilization. The department encourages maximizing public and clinical datasets to deepen knowledge of drug use trajectories, consequences, and risk/resilience in psychopathology. Projects should inform strategies for high-quality, effective drug abuse and HIV prevention and treatment, leveraging existing data to advance public health.
Opportunity ID: 337303
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-22-037 |
| Funding Opportunity Title: | Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.273 — Alcohol Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 10, 2022 |
| Last Updated Date: | Jan 10, 2022 |
| Original Closing Date for Applications: | Nov 15, 2024 |
| Current Closing Date for Applications: | Nov 15, 2024 |
| Archive Date: | Dec 21, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses State governments Small businesses County governments Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-22-037.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 337303 Full Announcement-RFA-DA-22-037 -> RFA-DA-22-037-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00271297 | Feb 04, 2022 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277846 | Nov 01, 2022 | Nov 15, 2024 | View |
Package 1
Mandatory forms
337303 RR_SF424_5_0-5.0.pdf
337303 PHS398_CoverPageSupplement_5_0-5.0.pdf
337303 RR_OtherProjectInfo_1_4-1.4.pdf
337303 PerformanceSite_4_0-4.0.pdf
337303 RR_KeyPersonExpanded_4_0-4.0.pdf
337303 PHS398_ResearchPlan_4_0-4.0.pdf
337303 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337303 RR_Budget_3_0-3.0.pdf
337303 RR_SubawardBudget30_3_0-3.0.pdf
337303 PHS398_ModularBudget_1_2-1.2.pdf
337303 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
337303 RR_SF424_5_0-5.0.pdf
337303 PHS398_CoverPageSupplement_5_0-5.0.pdf
337303 RR_OtherProjectInfo_1_4-1.4.pdf
337303 PerformanceSite_4_0-4.0.pdf
337303 RR_KeyPersonExpanded_4_0-4.0.pdf
337303 PHS398_ResearchPlan_5_0-5.0.pdf
337303 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337303 RR_Budget_3_0-3.0.pdf
337303 RR_SubawardBudget30_3_0-3.0.pdf
337303 PHS398_ModularBudget_1_2-1.2.pdf
337303 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
